Search
Foghorn Therapeutics Inc.
FHTXAdd to Watchlist
3.600USD
-0.270-6.98%
Close 09-23 16:00（ET）
211.36MMarket Cap
LossP/E TTM
FHTX Financials
See Foghorn Therapeutics Inc.'s financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Key Financial Ratios
Market Cap
211.36M
Dividend TTM
0.00
P/E TTM
-3.09
EPS TTM
-1.17
Revenue
30.91M
Net Profit
-86.62M
ROE
-470.38%
ROA
-31.33%
Foghorn Therapeutics Inc. Earnings Date
Latest Release
Aug 6, 2026
EPS / Forecast
-0.10/-0.26
Revenue / Forecast
16.07M/6.00M
Financial Statement Highlights
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FAQs
What is the total revenue of Foghorn Therapeutics Inc.?
According to Foghorn Therapeutics Inc.'s FY2025 earnings report, its total revenue reached 30.91M, with a year-on-year change of 22.60M.
What are the current assets of Foghorn Therapeutics Inc.?
According to Foghorn Therapeutics Inc.'s FY2025 earnings report, its current assets were 163.24M, with a year-on-year change of -34.60.
What are the total assets of Foghorn Therapeutics Inc.?
According to Foghorn Therapeutics Inc.'s FY2025 earnings report, its total assets of Foghorn Therapeutics Inc. were 198.10M, with a year-on-year change of -30.24.
What are the total liabilities of Foghorn Therapeutics Inc.?
According to Foghorn Therapeutics Inc.'s FY2025 earnings report, its total liabilities of Foghorn Therapeutics Inc. were 306.60M, with a year-on-year change of -6.95.
What is the total equity of Foghorn Therapeutics Inc.?
According to Foghorn Therapeutics Inc.'s FY2025 earnings report, its total equity of Foghorn Therapeutics Inc. was -108.50M, with a year-on-year change of -138.31.
What is the net operating income of Foghorn Therapeutics Inc.?
According to Foghorn Therapeutics Inc.'s FY2025 earnings report, its net operating income of Foghorn Therapeutics Inc. was -82.11M, with a year-on-year change of 18.13.
What is the net investment of Foghorn Therapeutics Inc.?
According to Foghorn Therapeutics Inc.'s FY2025 earnings report, its net investment of Foghorn Therapeutics Inc. was 112.04M, with a year-on-year change of 474.67.
What is the net financing of Foghorn Therapeutics Inc.?
According to Foghorn Therapeutics Inc.'s FY2025 earnings report, its net financing of Foghorn Therapeutics Inc. was 1.02M, with a year-on-year change of -99.03.
What is the Earnings Per Share (EPS) of Foghorn Therapeutics Inc.?
According to Foghorn Therapeutics Inc.'s FY2025 earnings report, its Earnings Per Share (EPS) was -1.18, with a year-on-year change of 25.25.
What is the net income of Foghorn Therapeutics Inc.?
According to Foghorn Therapeutics Inc.'s FY2025 earnings report, its net income was -74.28M, with a year-on-year change of 14.24.
What is the net margin of Foghorn Therapeutics Inc.?
According to Foghorn Therapeutics Inc.'s FY2025 earnings report, its net profit margin was -240.33, with a year-on-year change of 37.29.
What is the Return on Assets (ROA) of Foghorn Therapeutics Inc.?
According to Foghorn Therapeutics Inc.'s FY2025 earnings report, its Return on Assets (ROA) was -30.82, with a year-on-year change of -1.38.
What is the operating profit of Foghorn Therapeutics Inc.?
According to Foghorn Therapeutics Inc.'s FY2025 earnings report, its operating profit was -82.11M, with a year-on-year change of 18.13.